Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Cancer Biomarkers Market by Biomarker Type (Genetic, Protein), Cancer Type (Blood Cancer, Breast Cancer, Colorectal Cancer), Technology, Application, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 31.23 billion in 2024, at a CAGR 10.71% to reach USD 57.75 billion by 2030. Cancer biomarkers are substances or processes that can be measured in parts of ... Read More
-
Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 27.15% to reach USD 30.48 billion by 2030. Gene therapy is a medical procedure that introduces, alters, or corrects genetic ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Next-Generation Cancer Diagnostics Market by Technology (Clustered Regularly Interspaced Short Palindromic Repeats Diagnostics, DNA Microarrays, Lab-on-a-Chip & Reverse Transcriptase-PCR), Cancer Type (Bladder Cancer, Breast Cancer, Cervical Cancer), Application, Function - Global Forecast 2024-2030
... Cancer Diagnostics Market size was estimated at USD 9.77 billion in 2023 and expected to reach USD 12.02 billion in 2024, at a CAGR 24.12% to reach USD 44.36 billion by 2030. The next-generation cancer ... Read More
-
Tumor Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Tumor Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others), By Technology (Microarray, Real-Time Quantitative, Polymerase Chain Reaction (Q-PCR), Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F
... Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F Global Tumor ... Read More
-
Global Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032
... Regional Forecasts 2022-2032 Global Laboratory Developed Tests Market is valued at approximately USD 12.36 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.21% over the forecast period ... Read More
-
Asia Pacific Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032
... and Regional Forecasts 2022-2032 Asia Pacific Laboratory Developed Tests Market is valued at approximately USD 3.58 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.20% over the ... Read More
-
Europe Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032
... Regional Forecasts 2022-2032 Europe Laboratory Developed Tests Market is valued at approximately USD 2.60 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.63% over the forecast period ... Read More
-
US Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032.
... Regional Forecasts 2022-2032. US Laboratory Developed Tests Market is valued at approximately USD 3.47 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period ... Read More
-
Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis, historical and forecasted epidemiology as well as the Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis market trends in the United States, EU5 (Germany, ... Read More
-
Bladder cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Bladder cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Bladder cancer market report provides current treatment practices, emerging drugs, Bladder ... Read More
-
Ductal Carcinoma in Situ – Market Insight, Epidemiology, and Market Forecast – 2034
... Carcinoma in Situ, historical and forecasted epidemiology as well as the Ductal Carcinoma in Situ market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ductal Carcinoma in ... Read More
-
Esophageal Squamous Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Esophageal Squamous Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Esophageal Squamous Carcinoma market report provides current ... Read More
-
Gastric Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Gastric Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Gastric Cancer market report provides current treatment practices, emerging drugs, Gastric ... Read More
-
Inflammatory Breast Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Inflammatory Breast Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Inflammatory Breast Cancer market report provides current ... Read More
-
Metastatic Bone Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Metastatic Bone Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic Bone Cancer market report provides current ... Read More
-
Metastatic Uveal Melanoma (MUM) – Market Insight, Epidemiology, and Market Forecast – 2034
... Uveal Melanoma (MUM), historical and forecasted epidemiology as well as the Metastatic Uveal Melanoma (MUM) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic Uveal Melanoma ... Read More
-
Refractory Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Refractory Multiple Myeloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Refractory Multiple Myeloma market report provides current ... Read More
-
Relapsing Refractory Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034
... Refractory Multiple Myeloma, historical and forecasted epidemiology as well as the Relapsing Refractory Multiple Myeloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Relapsing Refractory Multiple ... Read More
-
Soft Tisue Sarcoma (STS) with lung metastases – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Soft Tisue Sarcoma (STS) with lung metastases, historical and forecasted epidemiology as well as the Soft Tisue Sarcoma (STS) with lung metastases market trends in the United States, EU5 (Germany, ... Read More
-
T-Cell Blood Cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the T-Cell Blood Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The T-Cell Blood Cancer market report provides current ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the CAR T-Cell Therapy for Multiple Myeloma, historical and forecasted epidemiology as well as the CAR T-Cell Therapy for Multiple Myeloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Melanoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Melanoma market report provides current treatment practices, emerging drugs, Melanoma market share of the individual ... Read More
-
CNS Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the CNS Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The CNS Lymphoma market report provides current treatment practices, emerging drugs, CNS ... Read More
-
Head and Neck Squamous Cell Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Head and Neck Squamous Cell Carcinoma, historical and forecasted epidemiology as well as the Head and Neck Squamous Cell Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
Research Assistance
